3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
19
Unknown
4
Active not recruiting
4
Withdrawn
3
Recruiting
3
Terminated
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Motor Activity
9
Neoplasms
4
Breast Neoplasms
3
Weight Loss
2
Ventricular Dysfunction, Left
1
Urinary Incontinence
1
Sexual Dysfunction, Physiological
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Polycystic Ovary Syndrome
1
Ovarian Neoplasms
1
Melanoma
1
Lymphoma
1
Leukemia
1
Insulin Resistance
1
Hypoxia
1
Hematologic Neoplasms
1
Heart Failure
1
Head and Neck Neoplasms
1
Fecal Incontinence
1
Fatigue
1
Cardiotoxicity
1
Carcinoma, Renal Cell
1
Cachexia
1
Brenner Tumor
1
Breast Diseases
1
Brain Neoplasms
1
Bone Metastases
1
Body Weight
1
Interventions
Docetaxel
56
Prednisone
36
enzalutamide
25
Leuprolide
24
Magnetic Resonance Spectroscopy
19
Abiraterone Acetate
19
bicalutamide
17
Radiotherapy
15
Goserelin
15
abiraterone
12
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
11
olaparib
9
Androgen Antagonists
9
gallium 68 PSMA-11
8
cabazitaxel
8
Radiotherapy, Intensity-Modulated
8
Metformin
8
Ketoconazole
8
Gonadotropin-Releasing Hormone
8
Cyclophosphamide
8
apalutamide
7
Doxorubicin
7
luprolide acetate gel depot
6
cabozantinib
6
Radiosurgery
6
Estramustine
6
Dexamethasone
6
Calcitriol
6
Biopsy
6
pembrolizumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Prostatic Neoplasms
×
Exercise
×
Clear all
NCT03365076
2023-01-09
EXIPOX
University Hospital of North Norway
Phase NA
Terminated
1 enrolled